Arvinas, Inc. announced that its Chief Medical Officer, Noah Berkowitz, M.D., Ph.D., will depart from the company on July 3, 2026. The company has initiated a search for a replacement. Arvinas, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted protein degradation therapies.
